Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GILD
VRTX
Add up to 3 more stocks
GILD
Gilead Sciences, Inc.
-0.75%
$143.72-1.09Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$178.44B
52W Range
$108.46 - $157.29
VRTX
Vertex Pharmaceuticals Incorporated
+0.17%
$515.44+0.88Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$130.82B
52W Range
$374.17 - $560.25
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 30.00 |
| Forward P/E | N/A | 27.49 |
| P/B Ratio | 15.09 | 6.46 |
| P/S Ratio | 5.86 | 10.36 |
| P/FCF Ratio | 13.76 | 34.46 |
| EV/EBITDA | N/A | 24.88 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.6% | 86.0% |
| Operating Margin | 39.7% | 38.6% |
| Net Margin | -10.6% | 34.9% |
| ROE | -27.4% | 21.8% |
| ROA | -6.6% | 16.1% |
| ROIC | -3.7% | 17.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.27 | 3.19 |
| Quick Ratio | 1.09 | 2.74 |
| Debt/Equity | 2.22 | 0.10 |
| Interest Coverage | 11.43 | 357.95 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.2% | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 10 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.